Clinical Trial Update: Fruquintinib Plus Capecitabine as Maintenance Treatment of RAS / BRAF Wild-type Metastatic Colorectal Cancer [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial exploring fruquintinib plus capecitabine as maintenance therapy for metastatic colorectal cancer with RAS/BRAF wild-type status is in Phase 1/P…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Capecitabine (capecitabine)
• Fruquintinib (fruquintinib)

Snippet

Sponsor: Chinese Academy of Medical Sciences | Conditions: Metastatic Colorectal Cancer | Phase 1, Phase 2 | Status: UNKNOWN